Cure8 news brief
Why This Matters
The study points to a possible noninvasive brain-based biomarker that correlates with intestinal fibrosis severity in Crohn’s disease, a complication that’s hard to detect and treat. This could eventually help identify patients at risk of stricturing disease earlier or supplement bowel imaging.
Who Should Pay Attention
Adults with Crohn’s disease (especially those at risk of strictures), gastroenterologists and radiologists who manage IBD imaging, and researchers studying gut–brain interactions, biomarkers, and AI-based imaging tools.
Study Snapshot
What To Know
Researchers at two centers in China combined multiparametric brain MRI (functional, structural, microstructural) with magnetization-transfer enterography and serum metabolomics in 109 participants.
They used recursive feature elimination to select 13 brain features and trained a machine-learning index that discriminated moderate-to-severe intestinal fibrosis from non-to-mild fibrosis with AUCs ~0.84–0.92 across datasets.
The brain index correlated with enterography magnetization-transfer measures and with presence of bowel stricture, and group differences included reduced cortical R2* and reduced low-frequency functional activity plus increased activity in the isthmus of the cingulate cortex.
The authors propose these neural signatures may track fibrotic change via gut–brain signaling, but causality is not established.
Keep In Mind
The index was trained against magnetization-transfer MRI measures (a proxy for fibrosis) and tested in internal validation cohorts; it is not yet a validated clinical test. Further replication, comparison with histology, and demonstration of added value over existing enterography are needed.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.